---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-044711"
form_type: "8-K"
ticker: "GALT"
cik: "0001133416"
company_name: "GALECTIN THERAPEUTICS INC"
filed_at: "2025-12-08T23:59:59+00:00"
generated_at: "2026-05-16T13:55:24.169734+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Galectin Therapeutics shareholders elect all 11 directors, approve say-on-pay, set frequency at 3 years

## Summary
- All 11 director nominees elected with >25M votes for each; highest was Benjamin S. Carson Sr. at 25.9M.
- Advisory say-on-pay resolution approved: 25.3M for, 639k against, 310k abstain.
- Shareholders chose a 3-year frequency for future say-on-pay votes (22.1M votes for 3 years).
- Ratification of Cherry Bekaert LLP as independent auditor for FY2025 passed with 45.5M for, 142k against.

## SEC filing metadata
- accession: 0001140361-25-044711
- form_type: 8-K
- ticker: GALT
- cik: 0001133416
- company_name: GALECTIN THERAPEUTICS INC
- filed_at: 2025-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133416/000114036125044711/0001140361-25-044711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133416/000114036125044711/ef20060738_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-044711
- JSON: https://secwatch.observer/filing/0001140361-25-044711.json
- Plain text: https://secwatch.observer/filing/0001140361-25-044711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.